CLINICAL_TRIALS
trial_result
· 2020-09-18
Clinical Trial Update: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease [Phase 2]
Summary
Phase 2 clinical trial evaluating pasireotide with or without cabergoline in patients with Cushing's disease; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Cushings Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-09-18